Ethicon adds new platform to surgical offerings
This article was originally published in Clinica
Executive Summary
In a bid to expand its surgical device portfolio, Ethicon Endo-Surgery has inked a deal to acquire privately-held SurgRx and its family of FDA-cleared EnSeal devices. The systems incorporate Redwood, California-based SurgRx's proprietary advanced bipolar tissue sealing technology, which combines high compression and controlled energy delivery to create strong vessel seals. Ethicon, a Johnson & Johnson company, said that the EnSeal will complement its current Harmonic line of ultrasonic devices used in open and laparoscopic procedures. Financial terms of the deal were not disclosed.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.